Variant report

Variant	nsv606461
Chromosome Location	chr7:26460409-26485860
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr7:26475249-26475253	K562	blood:	n/a	n/a
2	BHLHE40	chr7:26476481-26476501	K562	blood:	n/a	n/a
3	BHLHE40	chr7:26476800-26476807	K562	blood:	n/a	n/a
4	CBX3	chr7:26482604-26482981	K562	blood:	n/a	n/a
5	CEBPB	chr7:26474486-26474965	K562	blood:	n/a	n/a
6	CEBPB	chr7:26474549-26474589	A549	lung:	n/a	n/a
7	CEBPD	chr7:26474631-26475001	K562	blood:	n/a	n/a
8	CTCF	chr7:26476500-26476650	HepG2	liver:	n/a	n/a
9	CTCF	chr7:26481220-26481370	WERI-Rb-1	eye:	n/a	chr7:26481324-26481333
10	CTCF	chr7:26481240-26481390	SK-N-SH_RA	brain:	n/a	chr7:26481324-26481333
11	CTCF	chr7:26481260-26481410	WERI-Rb-1	eye:	n/a	chr7:26481324-26481333
12	CTCF	chr7:26479628-26479712	K562	blood:	n/a	n/a
13	CTCF	chr7:26483581-26483611	MCF-7	breast:	n/a	n/a
14	CTCF	chr7:26483540-26483624	MCF-7	breast:	n/a	n/a
15	CUX1	chr7:26479259-26479260	K562	blood:	n/a	n/a
16	E2F4	chr7:26479251-26479579	MCF10A-Er-Src	breast:	n/a	n/a
17	E2F6	chr7:26482702-26482909	K562	blood:	n/a	n/a
18	EBF1	chr7:26463330-26463439	GM12878	blood:	n/a	n/a
19	ELF1	chr7:26467598-26467893	K562	blood:	n/a	chr7:26467720-26467729 chr7:26467719-26467730 chr7:26467719-26467730 chr7:26467718-26467731
20	EP300	chr7:26481347-26481856	SK-N-SH_RA	brain:	n/a	n/a
21	EP300	chr7:26474664-26474981	K562	blood:	n/a	n/a
22	EP300	chr7:26460501-26460627	GM12878	blood:	n/a	n/a
23	ESR1	chr7:26480156-26480699	ECC-1	luminal epithelium:	n/a	n/a
24	ESR1	chr7:26480181-26480603	ECC-1	luminal epithelium:	n/a	n/a
25	ESR1	chr7:26480227-26480649	ECC-1	luminal epithelium:	n/a	n/a
26	ESR1	chr7:26480093-26480672	ECC-1	luminal epithelium:	n/a	n/a
27	ESR1	chr7:26480217-26480634	ECC-1	luminal epithelium:	n/a	n/a
28	FOS	chr7:26468895-26469132	MCF10A-Er-Src	breast:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
29	FOS	chr7:26468871-26469131	MCF10A-Er-Src	breast:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
30	FOS	chr7:26468905-26469139	MCF10A-Er-Src	breast:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
31	FOS	chr7:26468802-26469149	MCF10A-Er-Src	breast:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
32	FOSL1	chr7:26468706-26469208	HCT-116	colon:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
33	FOSL1	chr7:26468672-26469269	HCT-116	colon:	n/a	chr7:26468991-26469000 chr7:26468992-26468999 chr7:26468989-26469001 chr7:26468987-26468998 chr7:26468991-26468999
34	FOXA1	chr7:26463022-26463459	T-47D	breast:	n/a	chr7:26463302-26463317
35	FOXA1	chr7:26468647-26468827	T-47D	breast:	n/a	n/a
36	FOXA1	chr7:26480316-26480581	ECC-1	luminal epithelium:	n/a	n/a
37	FOXA1	chr7:26463111-26463438	T-47D	breast:	n/a	chr7:26463302-26463317
38	FOXA1	chr7:26478030-26478192	T-47D	breast:	n/a	n/a
39	GABPA	chr7:26480833-26481124	H1-hESC	embryonic stem cell:	n/a	n/a
40	GATA1	chr7:26474463-26475239	K562	blood:	n/a	chr7:26474767-26474774 chr7:26474829-26474838 chr7:26474767-26474774 chr7:26474871-26474878 chr7:26474820-26474837 chr7:26474792-26474804 chr7:26474866-26474877 chr7:26474760-26474781 chr7:26474831-26474841 chr7:26474767-26474774
41	GATA2	chr7:26480077-26481740	SH-SY5Y	brain:	n/a	chr7:26481103-26481114 chr7:26481502-26481509 chr7:26481465-26481473
42	GATA2	chr7:26465314-26465604	SH-SY5Y	brain:	n/a	n/a
43	GATA3	chr7:26481300-26481773	SH-SY5Y	brain:	n/a	chr7:26481502-26481509 chr7:26481465-26481473
44	GATA3	chr7:26472170-26472326	SH-SY5Y	brain:	n/a	n/a
45	GATA3	chr7:26475948-26476197	T-47D	breast:	n/a	chr7:26476047-26476063 chr7:26476050-26476059
46	GATA3	chr7:26481200-26481658	MCF-7	breast:	n/a	chr7:26481502-26481509 chr7:26481465-26481473
47	GATA3	chr7:26465279-26465631	SH-SY5Y	brain:	n/a	chr7:26465306-26465322 chr7:26465310-26465317 chr7:26465310-26465317 chr7:26465303-26465324 chr7:26465310-26465317
48	GATA3	chr7:26481073-26481821	MCF-7	breast:	n/a	chr7:26481103-26481114 chr7:26481502-26481509 chr7:26481465-26481473
49	GATA3	chr7:26481226-26481739	T-47D	breast:	n/a	chr7:26481502-26481509 chr7:26481465-26481473
50	GATA3	chr7:26480157-26480570	SH-SY5Y	brain:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:26480747-26480797	CMK	blood:	n/a
2	chr7:26467725-26467775	IMR90	lung:	fetal
3	chr7:26480747-26480797	LNCaP	prostate:	n/a
4	chr7:26467725-26467775	GM12878	blood:	n/a
5	chr7:26467725-26467775	HCM	heart:	n/a
6	chr7:26480747-26480797	HMEC	breast:	n/a
7	chr7:26467725-26467775	AG09309	skin:	n/a
8	chr7:26467725-26467775	U87	brain:	n/a
9	chr7:26467725-26467775	Caco-2	colon:	n/a
10	chr7:26467725-26467775	AG10803	skin:	n/a
11	chr7:26467725-26467775	HEEpiC	esophagus:	n/a
12	chr7:26467725-26467775	K562	blood:	n/a
13	chr7:26480747-26480797	HEEpiC	esophagus:	n/a
14	chr7:26480747-26480797	NB4	blood:	n/a
15	chr7:26467725-26467775	GM06990	blood:	n/a
16	chr7:26467725-26467775	HRE	kidney:	n/a
17	chr7:26480747-26480797	HCT-116	colon:	n/a
18	chr7:26480747-26480797	NHBE	bronchial:	n/a
19	chr7:26467725-26467775	NT2-D1	testis:	n/a
20	chr7:26480747-26480797	SK-N-SH	brain:	n/a
21	chr7:26480747-26480797	Caco-2	colon:	n/a
22	chr7:26467725-26467775	CMK	blood:	n/a
23	chr7:26480747-26480797	K562	blood:	n/a
24	chr7:26467725-26467775	MCF10A-Er-Src	breast:	n/a
25	chr7:26467725-26467775	HAEpiC	amniotic membrane:	n/a
26	chr7:26467725-26467775	Hepatocyte	liver:	n/a
27	chr7:26480747-26480797	A549	lung:	n/a
28	chr7:26467725-26467775	HL-60	blood:	n/a
29	chr7:26480747-26480797	SKMC	muscle:	n/a
30	chr7:26480747-26480797	AG09319	gingival:	n/a
31	chr7:26467725-26467775	NB4	blood:	n/a
32	chr7:26467725-26467775	HRCEpiC	kidney:	n/a
33	chr7:26480747-26480797	MCF-7	breast:	n/a
34	chr7:26480747-26480797	PrEC	prostate:	n/a
35	chr7:26467725-26467775	PrEC	prostate:	n/a
36	chr7:26480747-26480797	RPTEC	kidney:	n/a
37	chr7:26467725-26467775	BJ	skin:	n/a
38	chr7:26467725-26467775	GM19239	blood:	n/a
39	chr7:26480747-26480797	HUVEC	blood vessel:	n/a
40	chr7:26480747-26480797	HCPEpiC	choroid plexus:	n/a
41	chr7:26480747-26480797	ProgFib	skin:	n/a
42	chr7:26480747-26480797	BE2_C	brain:	n/a
43	chr7:26467725-26467775	HMEC	breast:	n/a
44	chr7:26480747-26480797	HL-60	blood:	n/a
45	chr7:26480747-26480797	HAEpiC	amniotic membrane:	n/a
46	chr7:26480747-26480797	SAEC	small airway:	n/a
47	chr7:26467725-26467775	AoSMC	blood vessel:	n/a
48	chr7:26467725-26467775	ovcar-3	ovarian:	n/a
49	chr7:26480747-26480797	SK-N-MC	brain:	n/a
50	chr7:26467725-26467775	Jurkat	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:26436548..26440946-chr7:26456240..26460952,5	K562	blood:
2	chr7:26468045..26469569-chr7:26481144..26484097,2	K562	blood:
3	chr7:26484588..26487248-chr7:26505154..26507165,2	MCF-7	breast:
4	chr7:26485853..26489218-chr7:26491458..26493571,3	K562	blood:
5	chr7:26474475..26476451-chr7:26482238..26484932,2	MCF-7	breast:
6	chr7:26456630..26459638-chr7:26463476..26466366,3	K562	blood:
7	chr7:26471171..26474068-chr7:26476646..26478928,2	K562	blood:
8	chr7:26427415..26429605-chr7:26480362..26482553,2	K562	blood:
9	chr7:26465831..26467819-chr7:26472769..26475702,2	K562	blood:
10	chr7:26485853..26488611-chr7:26491458..26493571,2	K562	blood:
11	chr7:26468045..26469569-chr7:26481144..26484097,2	K562	blood:
12	chr7:26474341..26476301-chr7:26479361..26485616,5	K562	blood:
13	chr7:26444484..26447098-chr7:26462634..26465453,2	MCF-7	breast:
14	chr7:26456740..26460595-chr7:26476772..26480334,4	K562	blood:
15	chr7:26448654..26450705-chr7:26456619..26460704,3	K562	blood:
16	chr7:26474475..26476451-chr7:26482238..26484932,2	MCF-7	breast:
17	chr7:26478024..26479720-chr7:26479844..26481619,2	MCF-7	breast:
18	chr7:26451757..26454537-chr7:26460111..26461633,2	K562	blood:
19	chr7:26471171..26474068-chr7:26476646..26478928,2	K562	blood:
20	chr7:26459230..26461137-chr7:26676682..26679366,2	K562	blood:
21	chr7:26455567..26459057-chr7:26461303..26464191,3	MCF-7	breast:
22	chr7:26435194..26437360-chr7:26480063..26481898,2	K562	blood:
23	chr7:26472363..26474501-chr7:26678553..26680517,2	K562	blood:
24	chr7:26465831..26467819-chr7:26472769..26475702,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SNX10-5	chr7:26469005-26469153	NONHSAT119639
2	lnc-KIAA0087-5	chr7:26460583-26460762	NONHSAT119638
3	lnc-SNX10-2	chr7:26479879-26480125	ENSG00000214870
4	lnc-KIAA0087-5	chr7:26469853-26470264	NONHSAT119638
5	lnc-SNX10-5	chr7:26469825-26470379	NONHSAT119639
6	lnc-SNX10-5	chr7:26469472-26469594	NONHSAT119639

Variant related genes	Relation type
ENSG00000214870	TF binding region
ENSG00000214870	CpG island
ENSG00000222004	chromatin interactions
ENSG00000214870	chromatin interactions
CKAP2	miRNA target sites

Extended variants
information (count: 826 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:826 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1229678	chr7:26460409-26460410	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs147112962	chr7:26460428-26460429	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs186717194	chr7:26460436-26460437	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs559123922	chr7:26460447-26460448	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs529691968	chr7:26460515-26460516	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs1919937	chr7:26460516-26460517	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs541548579	chr7:26460567-26460568	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs12669192	chr7:26460646-26460647	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs192443838	chr7:26460654-26460655	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
10	rs550584923	chr7:26460680-26460681	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
11	rs73072292	chr7:26460788-26460789	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs2158374	chr7:26460902-26460903	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs532876791	chr7:26460911-26460912	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs148098243	chr7:26460945-26460946	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs182010033	chr7:26460971-26460972	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs535270232	chr7:26460975-26460976	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs554744907	chr7:26460976-26460977	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs186345125	chr7:26461078-26461079	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs537019394	chr7:26461084-26461085	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs371596651	chr7:26461105-26461106	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs114461215	chr7:26461106-26461107	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs115000512	chr7:26461141-26461142	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs545700727	chr7:26461144-26461145	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs140941776	chr7:26461259-26461260	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs189906839	chr7:26461263-26461264	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs76406735	chr7:26461327-26461328	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs542033412	chr7:26461341-26461342	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs73072293	chr7:26461353-26461354	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs114530099	chr7:26461378-26461379	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs543833530	chr7:26461380-26461381	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs564082414	chr7:26461386-26461387	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs532999477	chr7:26461399-26461400	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs138829686	chr7:26461427-26461428	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs560117692	chr7:26461444-26461445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528665682	chr7:26461484-26461485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs547841081	chr7:26461526-26461527	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs568436660	chr7:26461547-26461548	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs73072295	chr7:26461558-26461559	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs550518305	chr7:26461559-26461560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs73286974	chr7:26461616-26461617	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs539493579	chr7:26461624-26461625	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs564920299	chr7:26461681-26461682	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs147485462	chr7:26461683-26461684	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs397842379	chr7:26461703-26461704	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs398004108	chr7:26461705-26461706	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs541385503	chr7:26461733-26461734	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs1229679	chr7:26461777-26461778	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs61238536	chr7:26461833-26461834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs555558612	chr7:26461834-26461835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs575201519	chr7:26461846-26461847	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Cancer	21183584	CNVD
abnormal development	18461090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21785460	CNVD
Follicular lymphoma	20505157	CNVD
Williams-beuren syndrome	22470819	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Lung adenocarcinoma	17086460	CNVD
Colorectal cancer	19455253	CNVD
Lung cancer	17086460	CNVD
Breast cancer	18852474	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:203 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:26446000-26471200	Weak transcription	Skeletal Muscle Female	skeletal muscle
2	chr7:26453400-26468400	Weak transcription	Pancreas	Pancrea
3	chr7:26453600-26462600	Weak transcription	Lung	lung
4	chr7:26458000-26465400	Weak transcription	Fetal Lung	lung
5	chr7:26458200-26463400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr7:26458400-26461400	Enhancers	K562	blood
7	chr7:26459400-26461400	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr7:26459800-26460600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr7:26459800-26460800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr7:26459800-26460800	Enhancers	iPS-20b Cell Line	embryonic stem cell
11	chr7:26459800-26460800	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr7:26459800-26461400	Enhancers	HUES48 Cell Line	embryonic stem cell
13	chr7:26460000-26460800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr7:26460000-26460800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr7:26460200-26460600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr7:26460200-26460800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr7:26460200-26460800	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr7:26460200-26460800	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr7:26460200-26461000	Enhancers	Primary hematopoietic stem cells	blood
20	chr7:26460200-26461200	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr7:26460200-26461400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr7:26460400-26460600	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr7:26460400-26460800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr7:26460400-26460800	Enhancers	H9 Cell Line	embryonic stem cell
25	chr7:26460400-26460800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr7:26460400-26460800	Enhancers	Fetal Kidney	kidney
27	chr7:26460400-26461200	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr7:26460400-26461400	Enhancers	H1 Cell Line	embryonic stem cell
29	chr7:26460400-26461600	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr7:26460600-26484600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr7:26460800-26461800	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr7:26460800-26465400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr7:26460800-26465800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr7:26460800-26466000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
35	chr7:26460800-26472200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr7:26461000-26466600	Weak transcription	Primary hematopoietic stem cells	blood
37	chr7:26461200-26465800	Weak transcription	HUES6 Cell Line	embryonic stem cell
38	chr7:26461400-26462600	Weak transcription	K562	blood
39	chr7:26461400-26465800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
40	chr7:26461600-26469800	Weak transcription	HUES64 Cell Line	embryonic stem cell
41	chr7:26461800-26462800	Enhancers	Primary monocytes fromperipheralblood	blood
42	chr7:26462600-26463200	Enhancers	Lung	lung
43	chr7:26462600-26463800	Enhancers	K562	blood
44	chr7:26463000-26463200	Enhancers	Sigmoid Colon	Sigmoid Colon
45	chr7:26463400-26463800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr7:26463800-26467800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr7:26463800-26468800	Weak transcription	K562	blood
48	chr7:26465400-26466200	Enhancers	Fetal Lung	lung
49	chr7:26465400-26466400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr7:26465600-26466200	Enhancers	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links